Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
94.42
-1.87 (-1.94%)
Feb 13, 2026, 3:00 PM CST

SHA:688266 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
24,99416,49414,01410,00814,11215,526
Market Cap Growth
47.53%17.70%40.02%-29.08%-9.11%-
Enterprise Value
24,03315,21312,6589,44313,02813,956
Last Close Price
94.4262.3152.9441.7058.8064.69
Forward PE
-35.5135.5135.51--
PS Ratio
33.6730.9536.2633.1174.13561.28
PB Ratio
21.7513.178.5212.7111.269.18
P/TBV Ratio
22.4513.708.9614.9813.0710.43
P/OCF Ratio
-431.73----
EV/Sales Ratio
32.3828.5432.7631.2468.44504.55
Debt / Equity Ratio
0.980.830.540.700.180.03
Net Debt / Equity Ratio
-0.84-0.92-0.83-0.63-0.78-0.91
Net Debt / EBITDA Ratio
6.326.633.821.032.114.47
Net Debt / FCF Ratio
4.6220.094.601.091.863.85
Asset Turnover
0.250.180.170.180.100.02
Inventory Turnover
0.400.260.300.370.190.04
Quick Ratio
1.681.712.081.573.3511.37
Current Ratio
1.851.882.221.773.6911.85
Return on Equity (ROE)
-11.11%-10.37%-24.27%-47.59%-31.38%-35.20%
Return on Assets (ROA)
-4.09%-4.60%-10.91%-19.70%-17.02%-20.80%
Return on Capital Employed (ROCE)
-11.80%-13.30%-22.70%-57.30%-37.10%-20.80%
Earnings Yield
-0.53%-0.84%-1.99%-4.57%-3.20%-2.06%
FCF Yield
-0.83%-0.35%-2.11%-4.59%-3.72%-2.59%
Buyback Yield / Dilution
-0.84%-3.71%-6.74%0.19%-2.20%-30.61%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.